The Clinical Relevance of Antinuclear Antibodies in Connective Tissue Diseases

References

• Ahearn J. M., Provost T. T., Dorsch C. A., Stevens M. B., Bias W. B., Arnett F. C. Interrelationships of HLA-DR, MB and MT phenotypes, autoantibody expression and clinical features in systemic lupus erythematosus. Arthritis Rheum. 1982; 25: 1031
   PubMed Web of Science ®Google Scholar
• Alarcon-Segovia D., Ruiz-Arguelles A., Fishbein E. Antibody penetration into living cells. Intranuclear immunoglobulin in peripheral blood mononuclear cells in mixed connective tissue disease and systemic lupus erythematosus. Clin. Exp. Immunol. 1979; 24: 1236
   Google Scholar
• Barada F. A., Andrews B. S., Davis J. S., Taylor R. P. Antibodies to Sm in patients with systemic lupus erythematosus, Correlation of Sm antibody liters with disease activity and other laboratory parameters. Arthritis Rheum. 1981; 24: 1236
   PubMed Web of Science ®Google Scholar
• Bell D. A., Maddison P. J. Serological subsets in systemic lupus erythematosus: an examination of autoantibodies in relationship to clinical features of disease and HLA antigens. Arthritis Rheum. 1980; 23: 1268
   PubMed Web of Science ®Google Scholar
• D'ascanio A., Tartarelli G. C., Neri R., Di Munno O., Mariani F., Bombardieri S. Anti-ENA antibodies in systemic lupus erythematosus: a follow-up study. Protides of the biological fluids, H. Peeters. Pergamon Press. 1985; 309
   Google Scholar
• Ebling F. M., Hahn B. H. Restricted subpopulations of DNA antibodies in kidneys of mice with SLE. Arthritis Rheum. 1980; 23: 392
   PubMed Web of Science ®Google Scholar
• Fritzler M. J., Mc Carty G. A., Ryan J. P., Kinsella T. D. Clinical features of patients with antibodies directed against proliferating cell nuclear antigen. Arthritis Rheum. 1983; 26: 140
   PubMed Web of Science ®Google Scholar
• Grant K. D., Adams L. E., Hess E. V. MCTD: mixed connective tissue disease, a subset with sequential clinical and laboratory features. J. Rheumatol. 1981; 8: 587
   PubMed Web of Science ®Google Scholar
• Hardin J. A. The lupus autoantigens and the pathogenesis of systemic lupus erythematosus. Arthritis Rheum. 1986; 29: 457
   PubMed Web of Science ®Google Scholar
• Hahn B. H. Antibodies to DNA. Epiphenomena or pathogens?. Immunology of Rheumatic Diseases, S. Gupta, N. Talal. Plenum Medical Company, New York and London 1985
   Google Scholar
• Houtman P. M., Kallenberg C. G.M., Limburg P. C., Huitema M. G., Van Rijswijk M. H., The T. H. Quantification of antibodies to nucleoribonucleoprotein by ELISA: relation between antibody levels and disease activity in patients with connective tissue disease. Clin. Exp. Immunol. 1985; 62: 696
   PubMed Web of Science ®Google Scholar
• Isemberg D. A., Hammond L., Fischer C., Griffiths M., Stuart J., Bottazzo G. F. Predictive value of SS-B precipitating antibodies in Sjogren's syndrome. Br. Med. J. 1982; 284: 1738
   PubMedGoogle Scholar
• Jonsson J., Norberg R. Symptomatology and diagnosis in connective tissue disease. Scand. J. Rheumatol. 1978; 7: 229
   PubMed Web of Science ®Google Scholar
• Koffler D., Schur P. H., Kunkel H. G. Immunological studies concerning the nephritis of systemic lupus erythematosus. J. Exp. Med. 1967; 126: 607
   PubMed Web of Science ®Google Scholar
• Lafer E. M., Valle R. P.C., Moller A., Nordheim A., Schur P. H., Rich A., Stollar B. D. Z-DNA-specific antibodies in human SLE. J. Clin. Invest. 1983; 71: 314
   PubMed Web of Science ®Google Scholar
• Izui J., Lambert P. H., Miescher P. A. In vitro demonstration of a particular affinity of glomerular basement membrane and collagen for DNA. J. Exp. Med. 1976; 144: 428
   PubMed Web of Science ®Google Scholar
• Lerner M. R., Steitz J. Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus. Proc. Natl. Acad. Sci., USA 1979; 77: 5405
   Google Scholar
• Maddison P. J., Provost T. T., Reichlin M. Serological findings in patients with ANA-negative systemic lupus erythematosus. Med (Baltimore) 1981; 60: 87
   PubMed Web of Science ®Google Scholar
• Maddison P. J., Skinner R. P., Vlachoyiannopoulos P., Brennand D. M., Hough D. Antibodies to nRNP, Sm, Ro(SS A) and La(SS B) detected by ELISA: their specificity and inter-relations in connective tissue disease sera. Clin. Exp. Immunol. 1985; 62: 337
   PubMed Web of Science ®Google Scholar
• Munves E. F., Schur P. H. Antibodies to Sm and RNP: prognosticators of disease involvement. Arthritis Rheum. 1983; 26: 848
   PubMedGoogle Scholar
• Neri R., Tartarelli G. C., D'ascanio A., Di Munno O., Del Bono L., Protti M., Bombardieri S. Anti-ENA antibodies in systemic lupus erythematosus: clinical Serological correlations. Protides of the biological fluids, H. Peeters. Pergamon Press. 1985
   Google Scholar
• Parker M. D. Ribonucleoproterin antibodies: frequency and clinical significance in systemic lupus erythematosus, scleroderma and mixed connective tissue disease. J. Lab. Clin. Med. 1973; 82: 769
   PubMed Web of Science ®Google Scholar
• Reichlin M. Clinical and immunological significance of antibodies to Ro and La in systemic lupus erythematosus. Arthritis Rheum. 1982; 25: 767
   PubMedGoogle Scholar
• Reyes P. A., Tan E. M. DNA binding property of Sm nuclear antigen. J. Exp. Med. 1977; 145: 749
   PubMedGoogle Scholar
• Scott J. S., Maddison P. J., Taylor P. V., Esscher E., Scott O., Skinner R. P. Connective tissue disease, antibodies to ribonucleoprotein and congenital heart block. N. Engl. J. Med. 1983; 309: 209
   PubMed Web of Science ®Google Scholar
• Sharp G. C., Irvin W. S., Tan E. M., Gould R. G., Holman H. R. Mixed connective tissue disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am. J. Med. 1972; 52: 148
   PubMed Web of Science ®Google Scholar
• Sharp G. C. Mixed connective tissue disease: current concepts. Arthritis Rheum 1977; 20: S181, (suppl.)
   Google Scholar
• Sharp G. C., Alspaugh M. A. Autoantibodies to Nonhistone Nuclear antigens. Their immunobiology and clinical relevance. Immunology of Rheumatic Diseases, S. Gupta, N. Talal. Plenum Medical Book Company, New York and London 1985
   Google Scholar
• Smeenk R., Westgeest T., Swaak T. Antinuclear antibody determination: the present state of diagnostic and clinical relevance. Scand. J. Rheumatol. 1985; 56: 78, Suppl.
   Google Scholar
• Sontheimer R. D., Gilliam J. N. DNA antibody class, subclass and complement fixation in SLE with and without nephritis. Clin. Immunol. Immunophatol. 1978; 10: 459
   PubMedGoogle Scholar
• Tan E. M. Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine. Adv. Immunol. 1982; 33: 167
   PubMed Web of Science ®Google Scholar
• Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothefield N. F., Schaller J. G., Talal N., Winchester R. J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982; 25: 1271
   PubMed Web of Science ®Google Scholar
• Tartarelli G. C., Neri R., D'ascanio A., Giovanelli L., Mariani F., Bombardieri S. Valutazione del valore predittivo degli anticorpi antinucleo nel monitoraggio clinico del lupus eritematoso sistemico mediante analisi discriminante. XXVII Congr. Soc. Ital. Reumatol. 1986, (Abstract)
   Google Scholar
• Urowitz M. B., Gladmann D. D., Tozman C. S., Goldsmith C. H. The lupus activity criteria count. J. Rheumatol. 1984; 11: 683
   Google Scholar
• Vitali C., Tavoni A., Rizzo G., Neri R., D'ascanio A., Cristofani R., Bombardieri S. HLA antigens in Italian patients with primary Sjogren's syndrome. Ann. Rheum. Dis. 1986; 45: 412
   PubMedGoogle Scholar
• Wasicek C. A., Reichlin M. Clinical and serological differences between systemic lupus erythematosus patients with antibodies to Ro versus patients with antibodies to Ro and La. J. Clin. Invest. 1982; 69: 835
   PubMedGoogle Scholar
• Weston W. L., Harmon C., Peebles C., Manchester D., Franco H. L., Huff J. C., Norris D. A. A serological marker for neonatal lupus erythematosus. Br. J. Dermatol. 1982; 107: 377
   PubMed Web of Science ®Google Scholar
• Wilson R. W., Provost T. T., Bias W. B., Alexander E. L., Edlow D. W., Hochberg M. C., Stevens M. B., Arnett F. C. Sjogren's syndrome: influence of multiple HLA-D region alloantigens on clinical and serological expression. Arthritis Rheum. 1984; 27: 1245
   PubMed Web of Science ®Google Scholar
• Winfield J. B., Faifermann J, Koffler D. Avidity of anti-DNA antibodies in serum and Ig G glomerular eluates from patients with SLE. Association of high avidity anti-native DNA antibody with glomerulonephritis. J. Clin. Invest. 1977; 59: 90
   PubMed Web of Science ®Google Scholar
• Winfield J. B., Brunner C. M., Koffler D. Serological studies in patients with systemic lupus erythematosus and central nervous system dysfunction. Arthritis Rheum. 1978; 21: 389
   Google Scholar
• Winn D. M., Wolfe J. F., Lindherg D. A., Frisboe F. H., Kingsland L., Sharp G. C. Identification of a clinical subset of systemic lupus erythematosus by antibodies to Sm antigen. Arthritis Rheum. 1979; 22: 1334
   PubMed Web of Science ®Google Scholar
• Winn D. M., Wolfe J. F., Harmon D., Sharp G. C. Characterization of a distinct nuclear acidic protein antigen (MA) and clinical findings in systemic lupus erythematosus patients with MA antibodies. J Clin. Invest. 1979; 64: 820
   PubMed Web of Science ®Google Scholar